undamentalytics Newsletter
Sign in

DuPont (DD) stock

Add to watchlist

Add holding +

NYSE: DD NYSE Industrial Conglomerates Next results ~November 3, 2026

DuPont makes advanced materials and components for healthcare, water, construction and industrial markets. Its products include Tyvek medical packaging and protective garments, specialty components for medical devices, water filtration products such as Amberlite resins and Filmtec reverse osmosis elements, Styrofoam insulation, Corian solid surfaces, Vespel shapes, Molykote lubricants and Cyrel printing plates.

Customers include biopharma and medical device manufacturers, industrial and municipal water operators, construction firms, and makers of vehicles, aircraft and packaging. Revenue comes from selling manufactured products and components, supported by proprietary process technology, patents and licensing of trade secrets, rather than subscriptions or advertising.

Following a 2025 reorganisation after separating its electronics business into Qnity, DuPont now reports two segments: Healthcare & Water Technologies and Diversified Industrials, alongside a Corporate function. The company has subsidiaries in roughly 50 countries and manufacturing in about 20, employs approximately 15,000 people worldwide, and holds around 6,100 patents and patent applications. It traces its current form to the 2019 spin-offs of Dow and Corteva from the former DowDuPont, followed by further divestitures of its nutrition, materials and mobility businesses.

Based on DuPont's 10-K filed February 17, 2026.

Stock price today

Loading chart…

Third-party market data · may be delayed

Fair value per share

Under review: data-quality checks not passed.

Price vs value

Under review: data-quality checks not passed. We'll show the comparison once resolved.

DuPont valuation: adjust assumptions and compare models →

Who’s trading

What company insiders, investment funds and members of Congress have been doing with the stock, from their own filings.

Value diary

Our note on each quarter DuPont files

Where DuPont stands after its latest 10-Q

Revenue for the twelve months to June 2026 was $6.99bn, up 3.3% on a year earlier, faster than 2.8% a quarter earlier. Free-cash-flow margin rose to 10.0% from -3.7% a year earlier. The diluted share count is up 147.6% on a year earlier, which dilutes existing holders. It passes 1 of our 2 financial-health checks.

Our model value for DuPont is under review, so past values are not shown until it is resolved.

Source: 10-Q filed August 4, 2026 on SEC EDGAR · Financials · Valuation

Written from the company's filings and our models when each quarter's report arrives. Figures in older notes are as published at the time. Not investment advice.

The Fundamentalytics view

Next results ~November 3, 2026 (estimated)

DuPont's trailing-twelve-month revenue grew 3.3% year on year, with a free-cash-flow margin of 10.0%.

Our discounted-cash-flow model values the business at ~$47 per share in the base case (~$32–$67 across growth scenarios) — model values under stated assumptions, not a price target.

Current signal Capital expenditure surging: TTM capex grew 129% year over year and now absorbs 4.9% of revenue.

Assembled from SEC-filed figures — the full workings are on this page and in our methodology. Observations, not recommendations.

Highlights

How we pick these

Strengths

  • Beating expectations. Earnings per share beat the analysts' consensus estimate in each of the last four quarters.

Things to watch

No figure in DuPont's latest results trips our warning thresholds.

Latest results: FY2026 Q2

Filed August 4, 2026
Earnings per share
$1.88 against an average estimate of $1.76: beat by 6.8%
Revenue
$1.82bn, up 4.0% on a year earlier
Share reaction
+4.3% in the first session after the results on August 4, 2026, against +1.6% for the S&P 500
Guidance given
net sales $3,660m to $3,690m (2H'26E); net sales $7,160m to $7,190m (Full Year 2026E)
Next report
November 3, 2026; average EPS estimate $1.88

DuPont's figures from its SEC filings and results release; estimates are the analysts' average. Not a recommendation.

Price chart

  • 1 day+0.9%
  • 1 week+3.7%
  • 1 month+8.7%
  • This year+18.6%
  • 1 year+40.3%
  • 5 years+54.7%
  • S&P 500 this year+11.2%

Closing prices to 2026-11-02. Price change only, dividends excluded.

Loading chart…

Third-party market data · may be delayed

At a glance

Trailing twelve months, from SEC filings

Profitability

Revenue (TTM)
$7B
Net margin
0.8%
EPS (TTM, diluted)
$0.39

Growth

Revenue growth
+3.3%
Change in growth rate
+0.5 pts
Share count change
−0.9%

Cash

Free cash flow (TTM)
$702M
FCF margin
10.0%
Stock pay % of revenue
0.5%

Earnings

Last results
November 3, 2026
Next results (est.)
February 9, 2027

News & updates

Updated November 3, 2026

Company announcements, filed results and changes that matter to shareholders.

  1. Results

    DuPont reports third quarter 2026 results

    DuPont said it issued a press release on November 3, 2026, to announce its financial results for the third quarter of 2026. The company filed a Form 8-K with the SEC to furnish this information to investors. No specific financial figures were included in the filing text.

    SEC 8-KRead source ↗
  2. Our research
  3. Announcement
  4. Agreement
  5. Results
  6. Guidance

Refreshed hourly when new source data is available. Summaries are checked against company releases and SEC filings. Company announcement headlines are labelled when a checked summary is unavailable.

Valuation

DuPont valuation models and calculator

Fundamentalytics rating

model v1.6 · 2026-11-03

Not rated: data-quality checks not passed.

Our value per share comes from a discounted-cash-flow model of DuPont's free cash flow after stock-based pay ( $444M, FY2026 Q2 TTM, with after-tax interest added back): growth for five years as below (the first two years from forecasts, guidance and the company's record), fading to 2.5%, discounted at 8.5%, then cash added and debt and other claims subtracted. These are model values under stated assumptions, not price targets or recommendations.

The inputs used by the models below have passed source checks. Individual model values are available below and in the interactive valuator. Their differences are shown explicitly; the platform combined value and recommendation remain withheld.

Valuation models

We value DuPont as an operating company, with every model that fits that kind of business. Cost of equity 9.3%: the 10-year Treasury yield (4.9%) plus a beta of 0.98 times a 4.5% equity risk premium.

Value per share by model
Model Value per share In the combined value?
Cash-flow model (DCF) Free cash flow to the firm (after stock pay, with after-tax interest added back), grown then faded to 2.5%, discounted at 8.5% as the firm rate, less debt and other claims. ~$47 ~$32–$67 Primary model, counts double
Forward price-to-earnings vs peers Next year's consensus earnings per share times peers' typical (harmonic-mean) forward price-to-earnings. Uses analysts' consensus estimates (third-party data), not our forecasts. — Does not apply: This model is withheld pending its input or assumption review.
Residual income Book value plus the present value of returns above the cost of equity, fading over ten years. — Does not apply: This model is withheld pending its input or assumption review.
Justified price-to-book Book value times (return on equity - growth) / (cost of equity - growth): steady-state returns. — Does not apply: This model is withheld pending its input or assumption review.
Combined value Individual source-checked model scenarios are available. The platform combined value and recommendation remain withheld. — Combined value withheld. Review the individual models and their assumptions.

Different models fail in different ways, so where several apply we average them rather than trust one. Peer-based models compare DuPont with Industrial Conglomerates in our coverage, using third-party market data. Model values are estimates under stated assumptions, updated as new filings arrive; not price targets or investment advice. How each model works.

Valuation multiples over time Market data may be delayed

At fiscal year end 20152016201720182019202020212022202320242025
Share price$72.71$83.68$106.99$82.21$70.70$80.09$92.43$80.09$91.58$92.54$119.12
Market value$42.6bn$44.4bn$57.0bn$63.5bn$52.8bn$58.9bn$50.3bn$40.0bn$41.2bn$38.8bn$49.9bn
+ Net debt (− = net cash)−$8.6bn$14.8bn−$13.4bn$6.9bn$15.9bn$13.1bn$8.8bn$4.5bn$5.5bn$5.4bn$2.5bn
Enterprise value$34.1bn$59.2bn$43.6bn$70.3bn$68.7bn$72.0bn$59.1bn$44.5bn$46.7bn$44.2bn$52.4bn
Multiples
Price / sales 0.9x0.9x0.9x2.8x2.5x2.9x4.0x3.1x6.2x5.8x7.3x
Price / earnings 5.5x10.3x49.2x16.5x105.9x—7.8x6.8x97.4x55.2x—
Price / free cash flow 10.9x——18.2x—20.3x33.7x—75.9x80.8xn/m
EV / EBITDA ———————————

Market value uses the period's diluted share count; figures for each fiscal year use that year's results and the price at year end. "Now" uses today's price and the last twelve months.

Moat

34 /100

Weak moat

How hard DuPont's competitive advantage looks for rivals to wear away, judged from 10 years of its own filings: returns on capital, pricing power, profit durability, cash conversion and discipline.

  • Returns on capital 0 / 20

    Net income has been a median 1.3% of total assets over 9 years.

  • Pricing power 8 / 20

    Gross margin has been a median 34.5%, moving by 6.8 percentage points (standard deviation) across 10 years.

  • Durability 0 / 20

    Net margin has been a median 5.0%; its worst year was -12.3%.

  • Cash conversion 11 / 20

    Free cash flow was positive in 5 of 7 years, at a median 8.6% of revenue.

  • Discipline 20 / 20

    The diluted share count fell 43.2% over five years; stock-based pay has been a median 0.5% of revenue.

AI disruption exposure: Medium. In this industry, AI could change how the product is made or sold, without replacing the core asset. The score above includes a 5-point deduction for that exposure (39 before it).

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

Forecasts and guidance

Next results: November 3, 2026, before the open. Analysts expect revenue of $1.8bn and EPS of $1.88 (range $1.85 to $2.01) for the quarter.

Analysts' consensus

Fiscal yearEPSGrowthRevenueGrowth
Current $7.26 +44% $7.2bn +5%
Next $7.99 +10% $7.4bn +4%

Next year's EPS estimate has moved +1.3% in 90 days, across 17 analysts.

How the EPS forecast has moved

The consensus EPS forecast for the current fiscal year is +1.4% on 90 days ago. In the last 30 days, 1 analyst raised DuPont's forecast and 2 cut it.

Consensus EPS forecast DuPont, last 90 days
$7.00 $7.50 $8.00 90 days ago 60 days ago 30 days ago 7 days ago Now Current fiscal year, 90 days ago: $7.16 Current fiscal year, 60 days ago: $7.26 Current fiscal year, 30 days ago: $7.26 Current fiscal year, 7 days ago: $7.26 Current fiscal year, Now: $7.26 $7.26 Next fiscal year, 90 days ago: $7.88 Next fiscal year, 60 days ago: $7.96 Next fiscal year, 30 days ago: $7.96 Next fiscal year, 7 days ago: $7.97 Next fiscal year, Now: $7.99 $7.99

Average of analysts' published estimates (third-party data).

View chart data
Period Current fiscal yearNext fiscal year
90 days ago $7.16$7.88
60 days ago $7.26$7.96
30 days ago $7.26$7.96
7 days ago $7.26$7.97
Now $7.26$7.99

Earnings against estimates

Quarter toEstimateActualSurprise
Jun 2026 $1.76 $1.88 +6.8%
Mar 2026 $1.45 $1.65 +13.6%
Dec 2025 $1.29 $1.38 +6.6%
Sept 2025 $2.94 $3.27 +11.2%

Adjusted EPS as companies report it, against the average analyst estimate.

Management guidance

Earnings release, August 4, 2026
  • Net sales Full Year 2026E $7,160m to $7,190m Raised
    “Net sales $3,660 - $3,690 $7,160 - $7,190” source
  • organic sales growth full-year 2026 about 4% growth Non-GAAP Raised
    “As a result of our second quarter outperformance, we are again raising the midpoint of our full-year 2026 operating EBITDA guidance to approximately $1.76 billion and adjusted EPS guidance to $7.24 per share, while increasing our expectation for organic sales growth to slightly above 4%," said Antonella Franzen, DuPont Chief Financial Officer.” source
  • Net sales 2H'26E $3,660m to $3,690m
    “Net sales $3,660 - $3,690 $7,160 - $7,190” source
  • Adjusted EPS Full Year 2026E $7.17 to $7.32 Non-GAAP Raised
    “Adjusted EPS (2) $3.65 - $3.80 $7.17 - $7.32” source
  • adjusted EPS guidance full-year 2026 about $7.24 Non-GAAP Raised
    “As a result of our second quarter outperformance, we are again raising the midpoint of our full-year 2026 operating EBITDA guidance to approximately $1.76 billion and adjusted EPS guidance to $7.24 per share, while increasing our expectation for organic sales growth to slightly above 4%," said Antonella Franzen, DuPont Chief Financial Officer.” source
  • Adjusted EPS 2H'26E $3.65 to $3.80 Non-GAAP
    “Adjusted EPS (2) $3.65 - $3.80 $7.17 - $7.32” source
Show 5 more items
  • Operating EBITDA Full Year 2026E $1,750m to $1,770m Non-GAAP Raised
    “Operating EBITDA (2) $890 - $910 $1,750 - $1,770” source
  • operating EBITDA guidance full-year 2026 about $1.76bn Non-GAAP Raised
    “As a result of our second quarter outperformance, we are again raising the midpoint of our full-year 2026 operating EBITDA guidance to approximately $1.76 billion and adjusted EPS guidance to $7.24 per share, while increasing our expectation for organic sales growth to slightly above 4%," said Antonella Franzen, DuPont Chief Financial Officer.” source
  • amortization expense of intangibles (pre-tax) 2026 about $275m
    “Management estimates amortization expense in 2026 associated with intangibles to be about $275 million on a pre-tax basis, or approximately $1.54 per share.” source
  • amortization expense of intangibles per share 2026 about $1.54
    “Management estimates amortization expense in 2026 associated with intangibles to be about $275 million on a pre-tax basis, or approximately $1.54 per share.” source
  • Operating EBITDA 2H'26E $890m to $910m Non-GAAP
    “Operating EBITDA (2) $890 - $910 $1,750 - $1,770” source

How earlier guidance turned out

  • Net sales, 2Q'26E guided about $1,800m Above range: $1,819m

Figures and quotations are management's, copied from the company's own press release (SEC 8-K exhibit) and checked word for word against it. Forward-looking statements are the company's expectations, not ours and not advice; guidance can change or be missed.

How our valuation uses these forecasts

Our cash-flow model grows DuPont's revenue by +4.5% next year and +4.0% the year after, then fades back toward its own record by year five. Next year's rate weighs analysts' consensus (+4.6%, weight 56%) , management guidance (+4.7%, weight 19%) and the company's own record (+4.0%, weight 25%) . How the weights are set.

Analyst recommendations

18 analysts, Oct 2026
Buy1478%
Hold422%
Sell00%

Monthly trend

  1. Oct 2026311418
  2. Sep 2026311317
  3. Aug 2026211417
  4. Jul 2026311317

Counts of recommendations published by analysts covering DuPont, by month. Source: Aggregated broker recommendations (third-party data). Aggregated counts only: we do not reproduce any firm's recommendation or price target, and these are not Fundamentalytics ratings.

Positioning

Short interest
4.0%
of tradable shares
Days to cover
4.99
at average volume
Short interest, 1 month
−4%
to October 15, 2026
Held by institutions
80%
of shares
Held by insiders
0.2%
of shares
Employees
15,000
full time

Consensus figures average analysts' published estimates (third-party data); guidance is the company's own. Neither is our forecast. Short interest is reported twice a month and lags. Market data may be delayed.

This section is general information, not investment advice or a personal recommendation, and it does not take account of your objectives or circumstances. Forecasts and guidance are estimates, not promises: companies miss their own guidance and analysts' figures are often revised. Prices can fall as well as rise, and you can lose money. See our disclaimer.

Share-price performance

Market data may be delayed

What moved the share price

Last 12 months +40.3%

$100.72 on October 31, 2025 to $141.30

ThenNowEffect
Revenue (last 12 months) $6.8bn $7.0bn +3.3%
P/S multiple 2.1x 2.8x +35.0%
Share count 139m 139m +0.6%

Biggest factor: p/s multiple. Loss-making at one end, so the split uses price/sales.

Last 3 years +71.2%

$82.52 on November 3, 2023 to $141.30

ThenNowEffect
Revenue (last 12 months) $12.5bn $7.0bn −44.2%
Net margin 37.7% 0.8% −97.9%
P/E multiple 2.8x n/m +12772.2%
Share count 158m 139m +14.1%

Biggest factor: p/e multiple.

The effects multiply back to the price change exactly. Results are the last 12 months as known on each date (filings assumed public 45 days after quarter end).

Return and risk by year

Calendar year 202120222023202420252026 to date
Return
DD+15%−13%+14%+1%+29%+19%
Industry peers (median)+13%−15%0%+8%−2%+11%
S&P 500+29%−18%+26%+25%+18%+11%
Months that ended higher
DD50%42%33%58%83%55%
S&P 50075%42%67%75%75%46%
Largest fall from a high during the year
DD−21%−40%−18%−21%−34%−19%
S&P 500−5%−25%−10%−8%−19%−9%

Worst fall since November 2, 2015: 73% from January 26, 2018 to March 23, 2020. Getting back needed a 267% gain, reached on November 5, 2025, 2053 days after the low.

Price behaviour

52-week range
$102.27 – $152.69
From 52-week high
−7.5%
vs 50-day average
+6.9%
vs 200-day average
+2.6%
Volatility (1 year)
30%
Beta vs S&P 500
1.03

Volatility is the annualised standard deviation of daily returns. Beta 1.5 means the shares typically moved 1.5% for each 1% move in the S&P 500 over the past year. Prices to November 2, 2026.

Share price after results

Next day
9 up, 2 down
typical move ±5.0%
After a week
10 up, 1 down
typical move ±5.2%
After a month
8 up, 3 down
typical move ±5.9%
Results releasedNext dayS&P 500 next day5 days21 days
August 4, 2026 +4.3% +1.6% +2.3% −5.5%
May 5, 2026 +10.3% +2.2% +11.3% +5.3%
February 10, 2026 +9.4% −0.3% +9.0% −3.4%
November 6, 2025 +0.4% −1.0% +2.4% +2.9%
August 5, 2025 −0.2% +0.3% +1.4% +9.4%
May 2, 2025 −1.1% +0.9% +1.1% +2.7%
February 11, 2025 +7.2% −0.2% +8.1% −1.3%
November 5, 2024 +3.0% +3.7% +0.5% +0.3%
July 31, 2024 +2.8% +0.2% −4.0% +3.7%
May 1, 2024 +7.2% +0.6% +7.9% +13.9%
February 6, 2024 +8.6% +1.1% +9.2% +16.9%

From the close before the release date to the close 1, 5 and 21 trading days after it, so releases before the open and after the close are both captured. Past moves don't predict future ones.

Fundamentals

Revenue (TTM) DuPont
$0 $5B $10B $15B FY23 Q3 FY24 Q2 FY25 Q1 FY26 Q2 Revenue (TTM), FY23 Q3: $12.3B Revenue (TTM), FY23 Q4: $6.6B Revenue (TTM), FY24 Q1: $5.2B Revenue (TTM), FY24 Q2: $3.8B Revenue (TTM), FY24 Q3: $2.5B Revenue (TTM), FY24 Q4: $6.7B Revenue (TTM), FY25 Q1: $6.7B Revenue (TTM), FY25 Q2: $6.8B Revenue (TTM), FY25 Q3: $6.8B Revenue (TTM), FY25 Q4: $6.8B Revenue (TTM), FY26 Q1: $6.9B Revenue (TTM), FY26 Q2: $7B $7B

Source: SEC EDGAR filings. Retrieved October 20, 2026.

View chart data
Period Revenue (TTM)
FY23 Q3 $12.3B
FY23 Q4 $6.6B
FY24 Q1 $5.2B
FY24 Q2 $3.8B
FY24 Q3 $2.5B
FY24 Q4 $6.7B
FY25 Q1 $6.7B
FY25 Q2 $6.8B
FY25 Q3 $6.8B
FY25 Q4 $6.8B
FY26 Q1 $6.9B
FY26 Q2 $7B
Revenue growth, TTM YoY DuPont
-100% 0% 100% 200% FY23 Q3 FY24 Q2 FY25 Q1 FY26 Q2 Revenue growth, TTM YoY, FY23 Q3: -6.7% Revenue growth, TTM YoY, FY23 Q4: -49.2% Revenue growth, TTM YoY, FY24 Q1: -59.3% Revenue growth, TTM YoY, FY24 Q2: -69.5% Revenue growth, TTM YoY, FY24 Q3: -79.8% Revenue growth, TTM YoY, FY24 Q4: 1.6% Revenue growth, TTM YoY, FY25 Q1: 29.6% Revenue growth, TTM YoY, FY25 Q2: 77.2% Revenue growth, TTM YoY, FY25 Q3: 176.7% Revenue growth, TTM YoY, FY25 Q4: 1.9% Revenue growth, TTM YoY, FY26 Q1: 2.8% Revenue growth, TTM YoY, FY26 Q2: 3.3% 3.3%

Source: SEC EDGAR filings. Retrieved October 20, 2026.

View chart data
Period Revenue growth, TTM YoY
FY23 Q3 -6.7%
FY23 Q4 -49.2%
FY24 Q1 -59.3%
FY24 Q2 -69.5%
FY24 Q3 -79.8%
FY24 Q4 1.6%
FY25 Q1 29.6%
FY25 Q2 77.2%
FY25 Q3 176.7%
FY25 Q4 1.9%
FY26 Q1 2.8%
FY26 Q2 3.3%
FCF margin (TTM) DuPont
-10% 0% 10% 20% 30% FY23 Q3 FY24 Q2 FY25 Q1 FY26 Q2 FCF margin (TTM), FY23 Q3: 6.4% FCF margin (TTM), FY23 Q4: 8.2% FCF margin (TTM), FY24 Q1: 13.8% FCF margin (TTM), FY24 Q2: 21.1% FCF margin (TTM), FY24 Q3: 24.8% FCF margin (TTM), FY24 Q4: 7.1% FCF margin (TTM), FY25 Q1: 2.2% FCF margin (TTM), FY25 Q2: -3.7% FCF margin (TTM), FY25 Q3: 1.7% FCF margin (TTM), FY25 Q4: 3.3% FCF margin (TTM), FY26 Q1: 5.8% FCF margin (TTM), FY26 Q2: 10.0% 10.0%

Source: SEC EDGAR filings. Retrieved October 20, 2026.

View chart data
Period FCF margin (TTM)
FY23 Q3 6.4%
FY23 Q4 8.2%
FY24 Q1 13.8%
FY24 Q2 21.1%
FY24 Q3 24.8%
FY24 Q4 7.1%
FY25 Q1 2.2%
FY25 Q2 -3.7%
FY25 Q3 1.7%
FY25 Q4 3.3%
FY26 Q1 5.8%
FY26 Q2 10.0%

Data: SEC EDGAR XBRL company facts (as filed in 10-K/10-Q); forms 10-K, 10-Q. Generated November 3, 2026. Definitions in our methodology.

Financial statements

US$ billions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year 2015 Dec 2015 2016 Dec 2016 2017 Dec 2017 2018 Dec 2018 2019 Dec 2019 2020 Dec 2020 2021 Dec 2021 2022 Dec 2022 2023 Dec 2023 2024 Dec 2024 2025 Dec 2025 LTM Jun 2026
Income
Revenue 48.8 48.2 62.5 22.6 21.5 20.4 12.6 13.0 6.6 6.7 6.8 7.0
Gross profit 11.0 10.5 12.7 20.6 11.5 13.3 4.6 4.6 2.2 2.2 2.4 2.5
Net income 7.7 4.3 1.2 3.8 0.5 −3.0 6.5 5.9 0.4 0.7 −0.8 0.1
Diluted EPS $13.02 $7.45 $2.15 $4.96 $0.67 −$4.01 $11.89 $11.75 $0.94 $1.68 −$1.86 —
Growth (year on year)
Revenue — −1.3% +29.7% −63.8% −4.8% −5.2% −38.4% +3.6% −49.2% +1.6% +1.9% +3.3%
Net income — −43.8% −73.2% — −87.0% −692.6% — −9.3% −92.8% +66.2% −210.8% —
Diluted EPS — −42.8% −71.1% — −86.5% −698.5% — −1.2% −92.0% +78.7% −210.7% —
Margins
Gross margin 22.6% 21.8% 20.3% 91.4% 53.4% 65.4% 36.6% 35.5% 32.8% 33.0% 34.5% 35.1%
Net margin 15.8% 9.0% 1.9% 17.0% 2.3% −14.5% 51.5% 45.1% 6.4% 10.5% −11.4% 0.8%
Free-cash-flow margin 8.0% −14.0% −2.1% 15.4% −4.9% 14.2% 11.9% −0.6% 8.2% 7.1% 3.3% 10.0%
Cash flow
Cash from operations 7.6 −3.0 −0.8 4.7 1.4 4.1 2.3 0.6 0.8 0.8 0.6 1.0
Capital spending 3.7 3.8 0.6 1.2 2.5 1.2 0.8 0.7 0.3 0.3 0.3 0.3
Free cash flow 3.9 −6.8 −1.3 3.5 −1.1 2.9 1.5 −0.1 0.5 0.5 0.2 0.7
Stock-based pay 0.4 0.3 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0
Free cash flow after stock pay 3.6 −7.0 −1.3 3.4 −1.2 2.8 1.4 −0.1 0.5 0.4 0.2 0.7
Balance sheet
Cash 8.6 6.6 13.4 8.5 1.5 2.5 2.0 3.7 2.4 1.8 0.7 1.7
Total debt 0.0 21.4 — 15.4 17.4 15.6 10.8 8.1 7.9 7.2 3.2 3.1
Net debt (negative = net cash) −8.6 14.8 −13.4 6.9 15.9 13.1 8.8 4.5 5.5 5.4 2.5 1.4
Diluted shares 587m 531m 533m 772m 746m 736m 544m 499m 450m 419m 419m —
Returned to shareholders
Dividends 2.3 2.5 3.4 3.5 1.6 0.9 0.6 0.7 0.7 0.6 0.6 0.4
Buybacks 1.2 0.9 1.0 4.4 2.3 0.2 2.1 — — — — —
Total returned 3.4 3.4 4.4 7.9 3.9 1.1 2.8 0.7 0.7 0.6 0.6 0.4

Source: SEC EDGAR XBRL company facts (US and foreign periodic filings); column headings link to the filing. EBITDA is operating income plus depreciation and amortisation. Free cash flow is cash from operations minus capital spending. Growth is left blank when last year's figure was a loss or under 2% of revenue. Share counts and EPS are restated for stock splits. A dash means the company didn't report the figure.

Financial health

4 of 6 checks passed · June 30, 2026
What it owns · $21.1bn
Short-term assets $4.9bnLonger-term assets $16.2bn
What it owes, and who funded it · $20.9bn
Short-term liabilities $2.0bnLonger-term liabilities $5.2bnShareholders' equity $13.8bn
  • Short-term assets cover short-term liabilities $4.9bn of assets due within a year against $2.0bn of liabilities due within a year.
  • Short-term assets cover long-term liabilities $4.9bn short-term assets against $5.2bn of longer-dated liabilities.
  • More cash than debt $1.7bn of cash against $3.1bn of debt.
  • Debt below 40% of shareholders' equity Debt is 23% of equity.
  • Debt burden no higher than five years ago Debt to equity moved from 40% to 23% over five years.
  • A year's operating cash flow covers at least 20% of debt $1.0bn of operating cash flow against $3.1bn of debt.
  • Operating profit covers interest at least five times over Interest not separately reported. Not assessable.

From DuPont's latest balance sheet as filed. Checks are fixed, documented rules (methodology), counted only where the company reports the figures — a dot means the filing doesn't break the item out. Descriptions of reported data, not advice.

Dividends, buybacks and capital spending

Dividends (TTM)
$417M
Diluted share count
−0.9%
year over year
Total shareholder yield
2.2%
dividends 2.2% + buybacks 0.0% of market value
Dividend payout ratio
758%
of net income paid out
R&D spending
0.3%
of revenue
Sales & admin spending
11.5%
of revenue
Days sales outstanding
48 days
receivables vs revenue

Competitors: side by side with peers

Closest by revenue in industrial conglomerates
Last 12 months unless stated DD IEP MMM CODI MATW LGPS Median
Revenue, last 12 months $7.0bn $10.6bn $25.2bn $1.8bn $1.1bn $148m $4.4bn
Revenue growth, last 12 months 3.3% 10.6% 1.7% −4.8% −31.8% 8.9% 2.5%
Revenue growth, 3-year average −17.7% −3.6% 10.7% 1.0% −15.8% — −3.6%
Revenue growth, latest quarter 4.0% 25.6% 1.0% −11.4% −29.6% — 1.0%
Gross margin 35.1% 16.8% 39.5% 44.6% 36.6% 19.8% 35.9%
Operating margin — — 18.8% 3.5% 6.3% 7.1% 6.7%
Operating margin, 3-year average — — 19.1% −1.2% 4.0% — 4.0%
Net margin 0.8% −5.0% 14.0% −5.3% −2.6% 3.4% −0.9%
Cash from operations / revenue 14.9% 1.0% 14.4% 6.2% −5.3% −9.9% 3.6%
Free-cash-flow margin 10.0% −2.3% 10.6% 4.4% −7.4% −17.3% 1.1%
Free-cash-flow margin, 3-year average 9.1% 5.7% 6.7% −4.4% −3.2% — 5.7%
Stock pay / revenue 0.5% — 0.8% — 1.6% 0.1% 0.7%
Change in share count −0.9% 9.7% −2.6% −0.2% 0.8% 9.0% 0.3%

Median of all 6 companies we cover in industrial conglomerates. Shaded: best of the six on that line (lowest for stock pay and share-count growth). 3-year figures average the last three 12-month periods; 3-year growth is compound annual. Source: SEC filings.

Where the revenue comes from

Fiscal year to December 31, 2025
Segments
Line of business Revenue Share YoY
Diversified Industrials $3.6B 52.8% ▼ 3.4%
Healthcare and Water Technologies $3.2B 47.2% ▲ 8.6%
Geography
Region Revenue YoY
United States $3.2B ▲ 1.6%
Asia Pacific $1.6B ▼ 0.4%
EMEA $1.5B ▲ 6.5%
China $708M ▼ 7.2%
Latin America $326M ▲ 1.2%
Canada $227M ▼ 2.2%

These categories overlap or exclude eliminations, so shares aren't shown.

From DuPont's 10-K filed February 17, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.

Who owns it

13F filings for June 30, 2026
Reported value
$13.4B
Institutions reporting
1,065
Shares held vs prior quarter
▲ 12058206.7%
Largest reported holders, June 30, 2026
Manager Value Shares Share of 13F value Shares QoQ
Blackrock, Inc. $1.4B 10.6M 10.8% New
Vanguard Capital Management LLC $1.2B 8.9M 9.1% New
Vanguard Portfolio Management LLC $869M 6.4M 6.5% New
Invesco Ltd. $514M 3.8M 3.8% New
Geode Capital Management, LLC $506M 3.7M 3.8% New
Morgan Stanley $368M 2.7M 2.8% New
Victory Capital Management Inc $319M 2.4M 2.4% New
Goldman Sachs Group Inc $278M 2.1M 2.1% New
Northern Trust Corp $217M 1.6M 1.6% New
Jpmorgan Chase & Co $206M 1.5M 1.5% New
Dimensional Fund Advisors LP $181M 1.3M 1.4% New
Bank Of America Corp $176M 1.3M 1.3% New

From Form 13F filings with the SEC ( quarterly data sets), as reported by each manager for June 30, 2026 and filed up to 45 days later. 13F reports cover long US-listed positions of managers above $100M only, so this is not DuPont's complete shareholder register. Values are as reported by the filers .

Insider trading activity

Full insider history and chart
Insider purchases History → $0 0 trades by 0 insiders, last 12 months Insider sales History → $607,254 3 trades by 2 insiders · 0% under pre-set plans
Net ▼ $607,254 net selling
Insider Date Trade Shares Price Value
Koch Lori CEO June 2, 2026 Sell 261 $48.82 $12,741
Koch Lori CEO November 28, 2025 Sell 9,011 $39.46 $355,574
Hoover Erik T. SVP & General Counsel November 28, 2025 Sell 6,005 $39.79 $238,939

From insiders' Form 4 filings with the SEC. Excludes awards, option exercises and shares withheld for tax. "Pre-set plan" means the filing marks the trade as made under a Rule 10b5-1 plan. See every insider trade since five years ago, on a price chart.

Trades by members of Congress

All 57 trades and filings

In the last 12 months, 1 member of Congress disclosed 1 purchase and 2 sales of DuPont shares.

  • Gilbert Ray Cisneros, Jr.(D-CA 31):Sale (full), $1,001 - $15,000, traded July 17, 2026, filed September 4, 2026
  • Gilbert Ray Cisneros, Jr.(D-CA 31):Purchase, $1,001 - $15,000, traded January 9, 2026, filed February 13, 2026
  • Gilbert Ray Cisneros, Jr.(D-CA 31):Sale (full), $1,001 - $15,000, traded November 12, 2025, filed December 15, 2025

Value ranges as filed; reports can arrive up to 45 days after a trade.

Earnings dates and SEC filings

Results announcements

Next expected around February 9, 2027 estimated from the company's past filing pattern, not announced

  • November 3, 2026
  • August 4, 2026
  • May 5, 2026
  • February 10, 2026
  • November 6, 2025
  • August 5, 2025

Recent SEC filings

Data status

When each part of this page on DuPont was last updated.

DataLast updatedSource
Share priceExchange closing prices
Financial statementsSEC 10-K and 10-Q filings
News and updatesCompany releases and SEC 8-K filings
Analyst estimatesAggregated analyst estimates
Valuation and scoresOur models, from the filed figures

How we build and check these figures: methodology and data sources.

DuPont in brief

What does DuPont do?
DuPont is a US-listed company in the industrial conglomerates industry. Its financial year ends in December.
What is DuPont's stock ticker?
DuPont trades under the ticker DD on NYSE. This page brings together its financial statements, valuation models, ownership and recent company updates.
What is DuPont's revenue, and how fast is it growing?
Over its most recent trailing twelve months, DuPont reported revenue of $7B, 3.3% higher than a year earlier, according to its SEC filings.
What is DuPont's free cash flow?
DuPont's free-cash-flow margin is 10.0% of revenue over the trailing twelve months.
Who are DuPont's largest institutional shareholders?
By value reported in 13F filings for June 30, 2026, the largest reported holders are Blackrock, Inc., Vanguard Capital Management LLC and Vanguard Portfolio Management LLC. 13F reports cover long US-listed positions of managers above $100M, filed up to 45 days after quarter end.
What is DuPont's market cap?
On December 31, 2025, DuPont's market capitalisation was about $49.9B and net debt of $2.5B. Market figures come from third-party market data and may be delayed.
Does DuPont pay a dividend?
Yes: DuPont paid $417M in dividends over the trailing twelve months, a dividend yield of 2.16% and a payout ratio of 758.2%.
How much debt does DuPont have?
DuPont's debt-to-equity ratio is 22.7%, from its latest balance sheet (40.2% five years earlier). The financial health section below sets out its other solvency checks.
Who are DuPont's competitors?
In our Industrial Conglomerates peer group, the companies closest to DuPont are Icahn Enterprises L.p., 3M, Compass Diversified Holdings, Matthews International Corp and Logprostyle Inc. The side-by-side comparison below sets their revenue, margins and growth against DuPont's.
Are insiders buying or selling DuPont stock?
Over the last 12 months, DuPont's directors and officers reported 0 open-market purchases and 3 sales on Form 4. The insider trading page charts every trade.
When is DuPont's next earnings date?
Around November 3, 2026, estimated from the spacing of its past results announcements (8-K filings). That is an estimate, not a confirmed date — DuPont announces its own schedule.